Free Trial

Quest Diagnostics (DGX) News Today

Quest Diagnostics logo
$259.46 -0.19 (-0.07%)
Closing price 11/13/2026 03:59 PM Eastern
Extended Trading
$259.68 +0.23 (+0.09%)
As of 11/13/2026 07:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Why Is Quest Diagnostics Down Today?

Quest Diagnostics Incorporated (NYSE: DGX) has a mix of supportive valuation and earnings-estimate news, alongside a sizeable insider sale. Shares recently reached a one-year high, while the latest reports offer no clear new operational catalyst.

  • Positive Sentiment: A Yahoo Finance article says DGX could be 31% undervalued following a push for the RESULTS Act, providing a potentially supportive policy and valuation angle. Quest Diagnostics stock could be undervalued following RESULTS Act push
  • Positive Sentiment: Zacks Research raised several earnings forecasts, including its FY2026 EPS estimate to $11.28 from $11.15 and its Q2 2027 estimate to $3.09 from $2.99. The improved forecasts may support investor confidence, though the FY2026 estimate remains close to the $11.29 consensus.
  • Positive Sentiment: Quest announced a quarterly dividend of $0.86 per share, equivalent to $3.44 annually and a stated yield of about 1.3%. The announcement coincided with DGX reaching a new one-year high. Quest Diagnostics hits a one-year high following dividend announcement
  • Neutral Sentiment: SVP Patrick Plewman sold 11,717 shares for about $3.02 million, reducing his holdings by 44.38%. The sale was made under a pre-arranged Rule 10b5-1 plan, which makes it a less definitive signal about his view of the company. Quest Diagnostics insider share sale
  • Negative Sentiment: Zacks lowered its Q4 2026 EPS estimate to $2.66 from $2.70, partially offsetting the upward revisions for other periods.
Posted 1+ days agoAI Generated. May Contain Errors.

Quest Diagnostics Latest News

Zacks Research Brokers Increase Earnings Estimates for DGX
Zacks Research Has Positive Outlook for DGX FY2026 Earnings
What Happened To People Who Bought Quest Stock At A High?
Quest Diagnostics Declares Quarterly Cash Dividend
Quest Diagnostics (NYSE:DGX) EVP Sells $5,482,482.10 in Stock

Quest Diagnostics Media Mentions By Week

Quest Diagnostics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

DGX
News Sentiment
▼
0.61

0.59
▲
Average
Healthcare
News Sentiment

Quest Diagnostics News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

DGX Articles
This Week
▼
21

6
▲
DGX Articles
Average Week

Quest Diagnostics Trends on MarketBeat

This week vs. last week
New Followers
1
Searches
2
-33%
Page Views
2,137
-42%
Get Quest Diagnostics News Delivered to You Automatically

Sign up to receive the latest news and ratings for DGX and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Quest Diagnostics dated 11/13/2026.
From Our Partners